Drug Shortage Report for TEVA-MOMETASONE
| Report ID | 167209 |
| Drug Identification Number | 02248130 |
| Brand name | TEVA-MOMETASONE |
| Common or Proper name | MOMETASONE FUROATE |
| Company Name | TEVA CANADA LIMITED |
| Market Status | MARKETED |
| Active Ingredient(s) | MOMETASONE FUROATE |
| Strength(s) | 0.1% |
| Dosage form(s) | OINTMENT |
| Route of administration | TOPICAL TOPICAL |
| Packaging size | 15 |
| ATC code | D07AC |
| ATC description | CORTICOSTEROIDS, PLAIN |
| Reason for shortage | Disruption of the manufacture of the drug. |
| Anticipated start date | |
| Actual start date | 2022-08-18 |
| Estimated end date | 2023-07-30 |
| Actual end date | 2023-07-20 |
| Shortage status | Resolved |
| Updated date | 2023-07-21 |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 30 NOVOPHARM COURT TORONTO, ONTARIO CANADA M1B 2K9 |
| Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v30 | 2023-07-21 | English | Compare |
| v29 | 2023-07-20 | French | Compare |
| v28 | 2023-07-20 | English | Compare |
| v27 | 2023-06-08 | French | Compare |
| v26 | 2023-06-08 | English | Compare |
| v25 | 2023-04-27 | French | Compare |
| v24 | 2023-04-27 | English | Compare |
| v23 | 2023-02-02 | French | Compare |
| v22 | 2023-02-02 | English | Compare |
| v21 | 2023-01-19 | French | Compare |
| v20 | 2023-01-19 | English | Compare |
| v19 | 2022-12-01 | French | Compare |
| v18 | 2022-12-01 | English | Compare |
| v17 | 2022-12-01 | French | Compare |
| v16 | 2022-12-01 | English | Compare |
| v15 | 2022-11-14 | French | Compare |
| v14 | 2022-11-14 | English | Compare |
| v13 | 2022-10-28 | French | Compare |
| v12 | 2022-10-28 | English | Compare |
| v11 | 2022-10-17 | French | Compare |